What These Ratios Tell Us About GlaxoSmithKline plc (ADR) (GSK)

Page 2 of 2

Despite these risks, I still rate Glaxo as a buy: the world’s population is getting richer and living longer, and that means that demand for Glaxo’s products will continue to grow.

The article What These Ratios Tell Us About GlaxoSmithKline originally appeared on Fool.com and is written by Roland Head.

Roland Head owns shares of GlaxoSmithKline. The Motley Fool recommends GlaxoSmithKline.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Page 2 of 2